Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-26.05	54.01	73.04
Graham Fair Price	29.90	42.06	32.38
PEG	-64.47	0.26	-0.73
Price/Book	-8.40	-9.07	-8.37
Price/Cash Flow	-86.77	34.16	258.17
Prices/Earnings	-38.85	18.88	30.88
Price/Sales	-8.40	6.20	6.77
Price/FCF	-86.77	34.16	258.17
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	3.88	0.31	0.30
Operating Margin	30.80	0.12	0.09
ROA	64.44	0.04	0.02
ROE	-0.07	-0.12	-77.29
ROIC	0.06	0.09	44.04
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-11.07
Dividends QOQ	-0.01	< 0.005	-43.65
EBIT QOQ	-0.34	0.50	45.60
EPS QOQ	-0.42	0.73	72.11
FCF QOQ	< 0.005	6.95	112271.58
Revenue QOQ	-0.09	0.15	62.63
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	116.80	111.56	-4.48
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.77	0.81	4.69
Debt/Capitalization	1.72	1.67	-2.95
Quick Ratio	0.08	0.18	127.54
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	-26.22	-25.58	2.44
Cash	2.14	6.13	186.60
Capex	-1.08	-0.67	38.06
Free Cash Flow	0.85	6.80	699.26
Revenue	32.41	37.42	15.45
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.23	1.17	-4.79
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	17.34	11.78	-32.04
Naive Interpretation	Member

06 - Financial Health · Bad

Rating